Masimo Co. (NASDAQ:MASI) Position Trimmed by Ace Management Global Ltd.

Ace Management Global Ltd. decreased its holdings in Masimo Co. (NASDAQ:MASI) by 95.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 47,694 shares of the medical equipment provider’s stock after selling 917,810 shares during the period. Masimo makes up approximately 100.0% of Ace Management Global Ltd.’s investment portfolio, making the stock its largest position. Ace Management Global Ltd. owned about 0.09% of Masimo worth $7,884,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. FMR LLC raised its holdings in Masimo by 41.2% in the 3rd quarter. FMR LLC now owns 6,756,618 shares of the medical equipment provider’s stock valued at $900,860,000 after acquiring an additional 1,970,883 shares during the last quarter. State Street Corp raised its holdings in Masimo by 0.7% in the 3rd quarter. State Street Corp now owns 1,438,814 shares of the medical equipment provider’s stock valued at $191,837,000 after acquiring an additional 10,179 shares during the last quarter. Westfield Capital Management Co. LP raised its holdings in Masimo by 23.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,394,056 shares of the medical equipment provider’s stock valued at $185,869,000 after acquiring an additional 262,370 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Masimo by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 792,886 shares of the medical equipment provider’s stock worth $105,741,000 after buying an additional 11,984 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA increased its holdings in shares of Masimo by 9.8% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 792,166 shares of the medical equipment provider’s stock worth $105,619,000 after buying an additional 70,440 shares during the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Stock Up 1.5 %

Masimo stock opened at $186.19 on Thursday. Masimo Co. has a fifty-two week low of $101.61 and a fifty-two week high of $194.88. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. The firm has a 50 day moving average price of $174.79 and a 200 day moving average price of $155.27. The company has a market capitalization of $10.04 billion, a PE ratio of 128.41 and a beta of 1.02.

Masimo (NASDAQ:MASI) last posted its earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.38. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm had revenue of $600.70 million during the quarter, compared to the consensus estimate of $593.35 million. Research analysts expect that Masimo Co. will post 4.1 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Raymond James raised their price target on shares of Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a report on Friday, December 27th. Piper Sandler raised their price target on shares of Masimo from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Stifel Nicolaus restated a “buy” rating and set a $190.00 price target (up previously from $170.00) on shares of Masimo in a report on Friday, November 22nd. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Wednesday, February 26th. Finally, Wells Fargo & Company raised their price target on shares of Masimo from $193.00 to $205.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $194.80.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.